SudhirSKushwahaMD

Cardiology • Rochester, MN

Heart Failure & Transplantation

Medical Director, Cardiac Transplant and VAD Program

Join to view full profile

Dr. Kushwaha is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kushwaha's full profile

Already have an account?

Office
200 1st St SW
Rochester, MN 55905
Phone+1 507-284-2511

Education & Training

Massachusetts General HospitalFellowship, Cardiovascular Disease, 1992 - 1995
Royal Free Hospital and University College London Medical SchoolClass of 1981

Certifications & Licensure

MN State Medical License 2000 - 2025
WI State Medical License 2014 - 2025
NC State Medical License 1999 - 2003
NY State Medical License 1995 - 2001
PA State Medical License 1992 - 1993
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Fellow (FACC) American College of Cardiology

Clinical Trials

Cardiac Rehab for Advanced Heart Failure-LVAD Candidates Start of enrollment: 2017 Apr 01
Withdrawn
Not Applicable
The Utility of Focused Frailty Interventions on Patients With Advanced Heart Failure Start of enrollment: 2018 May 04
Completed
Not Applicable

Publications & Presentations

PubMed

Reversibility of precapillary pulmonary hypertension and outcomes after heart transplantation bridged with left ventricular assist devices: Insight from the United Net...
Hilmi Alnsasra, Radha Kanneganti Perue, Fouad Khalil, Ohad Regev, Sudhir S Kushwaha
The Journal of Thoracic and Cardiovascular Surgery. 2025-01-01
Amyloidosis and Heart Transplantation in a New Era.
Melissa A Lyle, Juan Maria M Farina, Erin Wiedmeier-Nutor, Vanda Lindpere, Molly Klanderman
Clinical Transplantation. 2025-01-01
Incidence and risk factors for rejection after conversion from calcineurin inhibitor to sirolimus-based immunosuppression in orthotopic heart transplant recipients.
Sara S Inglis, Mohsin Abbas, Rabea Asleh, Armin Garmany, Byron H Smith
The Journal of Heart and Lung Transplantation. 2024-12-30

Lectures

21st Century Treatment of Heart Failure: Synchronizing Surgical & Medical Therapies for Better Outcomes
Cleveland Clinic - Cleveland, Ohio / The Cleveland Clinic Foundation, Cleveland, Ohio - 10/18/2012

Authored Content

Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
Join now to see all

Press Mentions

A Young Father’s Regenerative Bridge to TransplantDecember 21st, 2021
Study Sheds Light on Reverse-Order Heart-Liver Transplant's Benefits for Certain PatientsApril 2nd, 2021
Use of Left-Ventricular Assist Devices on Heart Failure Patients: Findings, Treatment Criteria ReleasedJuly 29th, 2015
Join now to see all

Professional Memberships

American College of Cardiology - ACC
Member

Other Languages

Hindi, Urdu